Active Toll-like receptor-7 triggering of chronic lymphocytic leukemia B-cells by imiquimod

[1]  M. Ahn,et al.  Phase I/II Trial , 2020 .

[2]  P. Lenert.  Classification, Mechanisms of Action, and Therapeutic Applications of Inhibitory Oligonucleotides for Toll-Like Receptors (TLR) 7 and 9 , 2010, Mediators of inflammation.

[3]  R. Spíšek,et al.  Toll‐like receptors on B‐CLL cells: expression and functional consequences of their stimulation , 2010, International journal of cancer.

[4]  Y. Shi,et al.  A phase I/II trial of TLR-7 agonist immunotherapy in chronic lymphocytic leukemia , 2010, Leukemia.

[5]  A. Faussat,et al.  Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-kappaB activation. , 2008, Nitric oxide : biology and chemistry.

[6]  N. McMillan,et al.  Molecular basis of pathogenesis, prognosis and therapy in chronic lymphocytic leukaemia , 2008, Cancer biology & therapy.

[7]  M. Schön,et al.  Imiquimod: mode of action , 2007, The British journal of dermatology.

[8]  P. Feugier,et al.  Expression of functional toll-like receptors by B-chronic lymphocytic leukemia cells , 2007, Haematologica.

[9]  Y. Shi,et al.  Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells , 2006, Leukemia.

[10]  Z. Darżynkiewicz,et al.  Relation of P-glycoprotein expression with spontaneous in vitro apoptosis in B-cell chronic lymphocytic leukemia. , 2004, Neoplasma.

[11]  J. Gribben,et al.  Cytotoxic T cell responses against immunoglobulin in malignant and normal B cells: implications for tumor immunity and autoimmunity. , 2003, Current pharmaceutical design.

[12]  C. Fegan,et al.  The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro. , 2003, Blood.

[13]  A. Büssing,et al.  Release of interleukin-6 in cultured B-chronic lymphocytic leukaemia cells is associated with both activation and cell death via apoptosis. , 1999, Anticancer research.

[14]  D. Levy,et al.  The Immune Response Modifier Imiquimod Requires STAT-1 for induction of Interferon, Interferon-Stimulated Genes, and Interleukin-6 , 1999, Antimicrobial Agents and Chemotherapy.

[15]  R. Foà,et al.  Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. , 1996, Blood.

[16]  R. Miller,et al.  Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction pathways , 1995, Molecular and cellular biology.

[17]  J. H. Pope,et al.  Spontaneous programmed death (apoptosis) of B‐chronic lymphocytic leukaemia cells following their culture in vitro , 1989, British journal of haematology.

[18]  W. N. Bailey.  An expression for , 1953 .